secwatch.observer — SEC 8-K summary
======================================

Issuer:     Biomea Fusion, Inc. (BMEA)
CIK:        0001840439
Form:       8-K
Filed at:   2025-06-17T23:59:59+00:00
Accession:  0001193125-25-142126
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BMF-650 preclinical shows 12-15% weight loss in obese monkeys; IND on track H2 2025
--------------------------------------------------------------------------------

- 28-day study in 15 obese cynomolgus monkeys; oral BMF-650 at 10 or 30 mg/kg daily.
- Weight loss of 12% (10 mg/kg) and 15% (30 mg/kg) from baseline at Day 28.
- Daily food intake reduced to 35g (10 mg/kg) and 16g (30 mg/kg) vs 109g for vehicle.
- IND submission for BMF-650 on track for second half of 2025.
- Full preclinical data set planned for upcoming medical conference presentation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840439/000119312525142126/0001193125-25-142126-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840439/000119312525142126/d915732d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-142126

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer